In the early hours of a trading day, long before markets open in New York or Copenhagen, laboratories across India are already awake. Scientists are calibrating machines, monitoring cell cultures, and running trials that will determine how the next generation of medicines reaches the world. This quiet intensity marks a turning point not just for India, but for global biotechnology itself. For decades, the biotechnology industry was anchored in the West. Breakthrough drugs, bi
